Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001933805-22-000001
Filing Date
2022-06-14
Accepted
2022-06-13 21:37:50
Documents
1
Effectiveness Date
2022-06-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5785
  Complete submission text file 0001933805-22-000001.txt   6805
Mailing Address 4314 13TH PLACE NE WASHINGTON DC 20017
Business Address 4314 13TH PLACE NE WASHINGTON DC 20017 205-837-8664
Lattice Therapeutics, Inc. (Filer) CIK: 0001933805 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-449072 | Film No.: 221013308